Neuropharmacology exam 2

  1. Enzyme: Choline + AcetylcoA --> Acetylcholine + coenzyme A
    Choline Acetyltransferase
  2. The amount of AcetylCholine release is reduced in the presence of (blank) that blocks Vesicular AcetylCholine Transporter.
    vesamicol
  3. A toxin found in the venom of the black widow spider,(blank) , leads to a massive release of ACh at synapses in the PNS
    Latrodectus mactans
  4. blocks ACh release at the

    neuromuscular junction by preventing fusion of synaptic vesicles with the nerve terminal membrane
    Botulinum toxin
  5. breaks down the acetylcholine into choline and acetic acid
    acetycholinesterase
  6. The choline transporter is subject to the blockade by the drug (blank) .

    As a result, the rate of ACh production declines
    hemicholinium-3 (HC-3)
  7. Acetylcholinisterase inhibitor that is able to cross the blood-brain barrier and exerts on the CNS. Poisoning by accidentally taking (it is a compound isolated from Calabar beans, the seeds of a woody plant found in the Calabar region of Nigeria) leads to an over-activity of central cholinergic synapses due to accumulation of ACh. The symptoms include slurred speech, mental confusion, hallucinations, loss of reflexes, convulsions, and even coma and death.
    Physostigmine
  8. Acetylcholinisterase inhibitors that have therapeutic significance: Since they do NOT cross the BBB, used for treatment of an autoimmune neuromuscular disorder,  myasthenia gravis.
    Neostigmine and

    pyridostigmine (used as an antidote against Sarin or Soman)
  9. DISEASE - develop antibodies against their own muscle cholinergic receptors.


    the loss of receptor function causes the patient’s muscles to be less sensitive to ACh, which in turn leads to severe weakness and fatigue.
    myasthenia gravis
  10. AcetylCholinisterase  inhibitors are irreversible (therefore it is permanent), which have been developed as “nerve gases” to be used as “chemical weapon”, 



    ØSymptoms of nerve gas poisoning due to rapid ACh accumulation and overstimulation of cholinergic synapses throughout both the CNS and PNS include slurred speech, mental confusion, hallucinations, loss of reflexes, convulsions, and even coma and death.
    Sarin and Soman
  11. contains two groups of cholinergic neurons: (1) the medial septal group that project cholinergic axons to the hippocampus and parahippocampal gyrus; and

    (2) the nucleus basalis group that project cholinergic axons to all parts of the neocortex, parts of limbic cortex and to the amygdala.




    plays an important role in cognitive functioning, and damage to this system may contribute to the dementia observed in Alzheimer's disease.
    Basal forebrain cholinergic system
  12. cholinergic interneurons in the (blank) play a role of balance with the dopaminergic neurons. A neurotransmitter imbalance happened in Parkinson’s disease (PD) due to

    neurodegeration of dopaminergic neurons (anti-cholinergic drugs are used in the early stages of PD).
    striatum (basal ganglia)
  13. exert a powerful excitatory

      influence on dopamine neurons in the   nucleus accumbens via mascarinic   cholinergic receptor subtype 5 (M5)   and nicotinic cholinergic receptors.   These cholinergic actions are involved   in the reinforcing effects of nicotine by   targeting some nuclei, like NA.
    The lateraldorsal and pedunculopontine tegmental nuclei
  14. two major cholinergic receptor subtypes:
    1) nicotinic (ionotropic receptors + fast excitatory) 

    • 2) muscarinic (metabotropic)
    • - Some activate the phosphoinositide second-messenger system (PKC), while others inhibit the formation of cyclic adenosine monophosphate (cAMP)-PKA


    - stimulation of K+ channel opening (via G-protein coupled to K+ channels). This leads to a hyperpolarization of the cell membrane and a reduction in cell firing.
  15. A chemical relative of Acetylcholine called (blank) is AChE resistant, so it continuously stimulates the nicotinic receptors and induces a depolarization block of the muscle cells.

    Nicotinic receptor agonist that causes depolarization block



    cause a persistent depolarization of the cell membrane, in which the resting potential of the

    membrane is lost and the cell cannot be excited

    until the agonist is removed and the membrane re-polarized.
    succinylcholine
  16. Blocks nicotinic receptors (antagonist)

    nicotinic antagonists (2 more)
    D-Tubocurarine

    Curare and mecamylamine
  17. Stimulates muscarinic receptors (agonist) (3 of them)
    muscarine

    pilocarpine

    arecholine
  18. blocks muscarinic receptors (antagonist)
    atropine scopolamine benztropine
  19. partial agonist for nicotinic receptors
    Varenicline
  20. tacrine inhibits acetylcholinisterase
    tacrine inhibits acetylcholinisterase
  21. What Enzyme?

    Glutamine -- > Glutamate
    Glutaminase
  22. Activation of the muscarinic receptors (blank) subtype in the cardiac muscle cells: a slowing of heart rate and a decrease in the strength of contraction – a decrease in the cardiac output
    M2
  23. Activation of the muscarinic receptors (blank) subtype in the smooth muscle cells: activation of smooth muscle cells, thus causing contraction of the muscle
    M3
  24. Activation of the muscarinic receptors (blank) subtype in the secretory glands: produces salivation, sweating, and lacrimation (tearing).
    M3
  25. ØPancreatic β-cells receive their parasympathetic innervation through the vagus nerve, which exhibits increased activity at the beginning of a meal. The resulting release of ACh acts on β-cell (blank) receptors to stimulate insulin secretion, thus regulating blood glucose levels during and following food consumption.
    M3
  26. Excitatory amino acid transporter locations:

    Excitatory amino acid transporter 3

    Excitatory amino acid transporter 4

    Excitatory amino acid transporter 1 and 2 

    Excitatory amino acid transporter 5
    • - most types of neurons
    • - purkinjie cells
    • - astrocytes 
    • - cells of the retina
  27. 3 ionotropic fast signaling glutamate receptors
    Kainate (KA) receptor: Named for the selective agonist kainic acid. This substance actually comes from a type of seaweed called Digenea simplex (Na+)


    AMPA receptor: Named for the selective agonist AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid), a synthetic amino acid analog. Most fast excitatory responses to glutamate are mediated by stimulation of AMPA receptors (Na+)


    NMDA receptor: The agonist of which is obvious NMDA (N-methyl-D-aspartate). Like AMPA, NMDA is a synthetic amino acid. The channel conducts not only Na+ but also significant amounts of Ca2+ that functions as a 2nd messenger in the postsynaptic cell to directly activate a 2nd-messenger system.
  28. Non-NMDA receptor antagonists:(blank) can block both AMPA and KA receptors, although it is somewhat more effective against the former subtype (AMPA). However, the compound has no effect on NMDA receptors.
    NBQX (6-nitro-7-sulfamoyl-benzo(f)-quinoxaline- 2,3-dione)
  29. A site within the NMDA receptor channel can bind (blank) ions.
    When the cell membrane is at the resting potential (-60/-70 mV), (blank) ions are bound to this site relatively tightly. This causes the receptor channel to be blocked even if glutamate and (blank) or (blank) are present to activate the receptor.
    B. However, if the membrane becomes depolarized, then the (blank) ions dissociate from the receptor and permit the channel to open if glutamate and (blank) or (blank) are present.

        Thus, Mg2+ ion removal is (blank) dependent!
    • -Mg2+
    • - Mg2+
    • - glycine or D-serine
    • - Mg2+
    • - glycine or D-serine
    • - voltage
  30. How many metabotropic glutamate receptors?

    fast or slow?
    eight

    slow
  31. (3 of them ) are anesthetic agents, non-competitive NMDA antagonists.

    - Results in no excitatory effects of glutamate
    Ketamine, MK-801 and PCP
  32. blank - refers to a persistent (at least 1 hour) increase in synaptic strength produced by a burst of activity in the presynaptic neuron, this mimics the environment or experience changes
    Long term potentiation
  33. cell death 

    - shrinking , programmed
    - swelling , lysis
    • - apoptosis
    • - necrosis
  34. The best established example of excitotoxic cell in humans due to food ingestion is the
    damage produced by ingesting large amounts of an excitatory amino acid called what?
    domoic acid.
  35. Enzyme:

    Glutamate --> GABA
    Glutamic acid decarboxylase
  36. GABA --- > Glutamate + Succinate

    what enzyme?
    GABA Aminotransferase
  37. Glutamate ---> Glutamine
    Glutamine synthetase
  38. The classic GABAA receptor agonist-like drug is called
    muscimol

    causes an intoxication characterized by hyperthermia (elevated body temperature), pupil dilation, elevation of mood, difficulties in concentration, anorexia (loss of appetite), ataxia, catalepsy, and hallucinations (similar to other hallucinogenic drugs such as LSD);
  39. best-known competitive antagonist for the GABAA receptor. It blocks the binding of GABA to the GABAA receptor, and when taken systemically, it has a potent convulsant effect



    GABA-lytic drug
    Bicuculline
  40. two other convulsant drugs that inhibit GABAA receptor function by acting at sites distinct from the binding site of GABA itself. 

    non-competitive antagonist
    Pentylenetetrazol (Metrazol) (once was used as a convulsant therapy for major depression)

    picrotoxin
  41. 3 GABA agonists that 



    1) an anxiolytic (anti-anxiety); 2) sedative-hypnotic (sedating and sleep-inducing); and 3) anticonvulsant profile.
    • -alcohol
    • -benzodiazepines - bind to sites distinct from GABA binding site
    • -barbiturates - bind to sites distinct from GABA binding site
    • - Neurosteroids
  42. GABAa ionotropic mechanism

    GABAb metabotropic mechanism
    - Open Cl- channels (Cl- influx)

    - Open K+ channels (K+ move outside cell) and close Ca2+ channels

    both hyperpolarize inhibit
  43. the withdrawal symptoms that occur after abstinence from a drug,especially a narcotic, to which one is addicted.

    , it promotes drug-taking behavior through a process of negative reinforcement

    Drug dependence is the symptom of addiction that becomes evident when repeated drug administration is withdrawn
    Abstinence syndrome
  44. After dependence has taken place - dominance of negative reinforcement mediated by the anti-reward system, meaning that reward develops an opposing effect.
    “Compulsive”
  45. Drug reward before dependence (non-addiction) has occurred - dominance of positive reinforcement mediated by the reward system (reward circuit involved).
    “Impulsive”
  46. Euphoric followed by dysphoric feelings reported by subjects smoking cocaine paste, in that plasma cocaine was still present, but the positive euphoric state was replaced by a negative hedonic state (fatigue, depression, anxiety, and craving

    what is this?
    – allostatic change.
  47. (so called “hot” drug-related) that connects the anterior cingulate cortex (ACC) with the Nucleus accumbens and is involved in emotional drive and motivation
    ventromedial circuit
  48. dorsolateral circuit (“cold” non-drug related) that projects from the dorsolateral PFC (DLPFC) to the (blank)  and is particularly important for executive function
    dorsolateral caudate nucleus (striatal region)
  49. An orbitofrontal circuit that projects from the orbitofrontal cortex (OFC) to the (blank) and is associated with behavioral inhibition and impulse control - self-constraint.
    ventromedial caudate (striatal region)
  50. Positron emission tomography (PET) imaging (scan) with radiolabeled (blank) measures regional (blank).
    -fluorodeoxyglucose

    - glucose uptake and metabolism
  51. Fermentation reaction reactants and products
    reactants - sugar

    products - ethanol and carbonic gas
  52. blood alcohol content to produce measurable behavioral effects
    0.04%
  53. absorbs 10% of alcohol
    stomach
  54. absorbs 90% of alcohol
    small intestine
  55. What enzyme?

    Alcohol --> Acetaldehyde
    alcohol dehydrogenase
  56. What enzyme?

    Acetaldehyde ---> Acetic acid
    acetaldehyde dehydrogenase
  57. Acetic acid undergoes oxidation to form
    Carbon dioxide , Water, and energy
  58. The blood alcohol level is lethal
    0.45%
  59. blood alcohol content with vomiting
    0.15%
  60. blood alcohol concentration with unconsciousness
    0.35%
  61. blood alcohol concentration for legal intoxication
    0.08%
  62. which involves the accumulation of triglycerides inside liver cells. The liver normally takes up and metabolizes fatty acids as part of the digestive process; however, when alcohol is present, it is metabolized first, leaving the fat for storage.
    Fatty liver
  63. which is serious and potentially lethal condition developed due to that individuals have abused alcohol for many years.  liver cell damage (cell death occurs) is apparently caused by accumulation of high levels of acetaldehyde (a metabolite of alcohol formed in the liver). Symptoms include inflammation of the liver, fever, yellowing of the skin (jaundice), and pain.
    Alcoholic hepatitis:
  64. The death of liver cells due to hepatitis stimulates the formation of scar tissue. 

    blood vessels carrying oxygen are cut off leading to further cell death.

    permanent irreversible.
    Alcoholic cirrhosis:
  65. close to the genes for the D4 dopamine receptor and tyrosine hydroxylase
    chromosome 11p
  66. near the gene for the GABAA receptor complex
    chromosome 4p
  67. what drug inhibits ALDH, the enzyme that converts acetaldehyde to acetic acid in the normal metabolism of alcohol?
    disulfiram (antabuse)
  68. what drug reduces the positive feelings and

    subjective "high" of alcohol by blocking the effects of alcohol-induced endorphin release.

    opiate receptor antagonist

    reduce reinforcement
    Naltrexone
  69. what drug acts as a partial antagonist at NMDA receptors and significantly reduces the effect of glutamate increase that occurs during alcohol withdrawal in rats. This may explain its therapeutic effects on withdrawal symptom relief.

    also has a chemical structure similar to GABA and returns basal GABA levels
    Acamprosate
  70. Animal studies suggest that blocking the (blank) for substance P reduces alcohol consumption and relapse behavior after withdrawal by alleviating anxiety symptoms.
    neurokinin-1 receptors (NK1R)
  71. The principal active ingredient in opium is called
    morphine
  72. Morphine group 

    Codeine group

    Heroin group
    Hydroxy (-OH)

    Methoxy (-OCH3 exchanged for one OH)

    - codeine less analgesic and less side effects

    Heroin (2 acetly groups exchanged for 2 OH)
  73. Chemical modifications of the morphine molecule also produce pure competitive antagonists such as
    naloxone and nalorphine
  74. morphine , codeine , thebaine, papaverine
    natural narcotics
  75. heroin , oxycodone, hydromorphine, etorphine
    semisynthetic narcotics
  76. enkephalins, endorphins, dynorphins
    endogenous opioids (neuropeptides)
  77. pentazocine, meperidine, fetanyl, methadone, LAAM, propoxyphene
    totally synthetic narcotics

    reduced dependence less respiratory depression and less potent than morphine and less constipation
  78. highest potency inhibiting electrically induced contracting intestine guinei pigs for opiods/ opiates
    etorphine
  79. highest potency inhibiting guinei pig ileum twitch and analgesia in humans
    etorphine
  80. what opioid receptor ?

    With a high affinity for morphine and related opiate drugs and the widest distribution in both the brain and spinal cord
    The μ-receptor
  81. what opioid receptor?

    They are predominantly found in forebrain structures such as the neocortex, striatum, olfactory areas, substantia nigra, and nucleus accumbens
    The δ-receptor
  82. what opioid receptor?

    With a very distinct distribution found in the sub-cortical areas, like striatum and amygdala, but additionally has a unique distribution in the hypothalamus and pituitary
    κ-receptors
  83. what opioid receptor?

     localization in the spinal cord, raphe nuclei, periaqueductal gray (PAG) and limbic areas suggests a significant role in analgesia (anti-nociception), feeding, learning, motor function, and neuroendocrine regulation.
    NOP-Rs
  84. All four opiate receptors have been successfully cloned having between blank and blank amino acids
    370-400
  85. pro-opiomelanocortin or POMC (267 amino acids), pro-enkephalin (267 amino acids), pro-dynorphin (254 amino acids), and pro-nociception/orphanin FQ (180 amino acids);
    four large propeptides opiods
  86. üIn addition, a group of peptides called (blank) , bind quite selectively to the µ-receptor and are as potent as morphine in relieving pain.
    endomorphins
  87. pituitary gland has high concentrations of which propeptide?
    Pro-opiomelanocortin (267 AA)
  88. what opioid receptor these bind to?

    Enkephalins
    Dynorphin
    Endorphin
    • δ-receptors
    • κ-receptor
    • µ- and δ-receptors, but bind preferentially to the µ-receptors
  89. opioids and N/OFQ work by both of those mechanisms to 1). open K+ channels and close Ca2+ channels (G-protein-coupled to channels); 2). inhibit adenylyl cyclase activity (effector enzyme to trigger 2nd messenger).


    The overall effects of opiate-like opioid on nerve cell function include the 1) reduction of membrane excitability; 2) subsequent slowing of cell firing and 3) the inhibition of neurotransmitter release.

    The opioid receptor types are linked to G-proteins (metabotropic receptors);



    ØOpioid receptor-mediated cellular changes are inhibitory
    opioids and N/OFQ work by both of those mechanisms to 1). open K+ channels and close Ca2+ channels (G-protein-coupled to channels); 2). inhibit adenylyl cyclase activity (effector enzyme to trigger 2nd messenger).


    The overall effects of opiate-like opioid on nerve cell function include the 1) reduction of membrane excitability; 2) subsequent slowing of cell firing and 3) the inhibition of neurotransmitter release.

    The opioid receptor types are linked to G-proteins (metabotropic receptors);



    ØOpioid receptor-mediated cellular changes are inhibitory
  90. opioid Postsynaptic inhibition (axodendrtic or axosomatic):
    open K+ channels
  91. axoaxonic opioid inhibition
    activate Gi protein linked to Ca2+ channel to close Ca2+ channels

    inhibit adenylyl cyclase then cAMP then PKA
  92. which pain fibers carry pain signal fastest Aδ- fibers or C-fibers and why?
    Aδ cuz they myelinated while C-fibers are unmyelinated so slow conduction
  93. Where do early pain signals go?
    Primary and secondary somatosensory cortex
  94. Blank and blank are especially activated by late pain information
    Anterior cingulate cortex, secondary somatosensory cortex and other limbic areas
  95. Endogenous analgesic system. The most important descending pathways begin in the pariaqueductal gray (PAG). The PAG is a brain area rich in endogenous opioid peptides and high concentrations of opioid receptor, particularly (blank) and (blank).

    The neurons begin in the PAG and end on cells in the (blank), including the serotonergic cell bodies of the (blank), and noradrenergic cell bodies of the (blank).
    µ and κ

    medulla

    nucleus of the raphe nuclei

    locus coeruleus
  96. Neurons of the PAG decend to (blank)

    then (blank) and (blank) neurons descend to the (blank) to modulate the transmission of the pain signal at that level
    brain stem nucleus of the raphe and the locus coeruleus

    serotinergic and noradrenergic

    spinal cord
  97. β-endorphin (endogenously) inhibits the inhibitory effects of GABA in the (blank) , this is called (blank) and this allowing the firing rate of the (blank) cells to increase  and the cells to release more (blank) in the (blank).

    They can decrease the release of GABA by (blank) or reducing (blank) on GABA terminals (axoaxonic inhibition);
    Ventral tegmental area 

    disinhibition

    mesolimbic dopaminergic 

    dopamine

    nucleus accumbens (NA)

    opening K+ channels

    Ca2+ influx
  98. Dynorphins inhibit the release of dopamine from mesolimbic dopaminergic cells by (blank)

    no dopamine is release in the (blank)
    preventing Ca2+ entry

    nucleus accumbens
  99. α-adrenergic agonist used for opiate withdrawal that reduce cell hyperexcitability by rebound by activating noradrenergic autoreceptors to reduce norepinephrine release
    Clonidine
  100. (two of them ) drug used in treatment of heroin addiction
    Methadone

    buprenorphine (Buprenex)
  101. VGLUT1 gene expression occurs primarily in the blank and blank, whereas VGLUT2 gene expression is found mostly in blank.
    cortex and hippocampus 

    subcortical structures
  102. activation of NMDA receptor channels needs more sources of excitatory events or stronger stimuli to remove the Mg2+ block. That is, the NMDA receptor usually plays as a kind of biological

    .
    “coincidence detector”
  103. allylglycine, thiosemicarbazide, and 3-mercaptopropionic acid
    block GABA synthesis by inhibiting glutamic acid decarboxylase including
  104. GABA 1 and 2 transporters are found in
    neurons and astrocytes
  105. GABA 3 transporters are found in
    astrocytes only
  106. an irreversible inhibitor of GABA-Transporter and thereby elevates GABA levels in the brain. 

    licensed for the treatment of certain types of epilepsy.
    Vigabatrin
  107. 2 α, 1 β, 1 γ & 1 δ

    what receptor?
    acetylcholine ionotropic receptor
  108. (1) two α-subunits, two β-subunits, and one γ-subunit or (2) two α-subunits, one β-subunit, and two γ-subunits

    what receptor?
    GABA ionotropic receptor
  109. When a BDZ, such as (blank) binds to the BDZ binding sits, it increases the potency of GABA to open the Cl- channels, good for anxiolytic action. However, BDZs cannot activate the GABAA receptor by themselves; thus, they have no effect in the absence of GABA.
    diazepam (trade name Valium)
  110. A selective GABAB receptor agonist called (blank) has been used for a number of years as a muscle relaxant and anti-spastic agent
    baclofen (Lioresal)
Author
JAM41MAN
ID
339045
Card Set
Neuropharmacology exam 2
Description
exam 2 UTA
Updated